IACTA Pharmaceuticals Licenses NM133 from Nanomerics for Treatment of Dry Eye
IACTA Pharmaceuticals, Inc., a privately held pharmaceutical company, has acquired the North American rights to…
IACTA Pharmaceuticals, Inc., a privately held pharmaceutical company, has acquired the North American rights to…
UltraCharge Limited (“UltraCharge” or “the Company”, ASX: UTR) has reported significant technical advancements in the development…
I-Minerals lnc. has been advised by German Institute of Diabetes “Gerhardt Katsch” Karlsburg (“IDK”), in…
Zelfo Technology (ZT) has reached an important milestone in its technical development program and will…
Founded back in 2001, and most well known for being pioneers in semiconductors and nanotechnology,…
XG Sciences, Inc. (XGS), a supplier of graphene nanoplatelets and value-added products containing graphene nanoplatelets,…
The need to produce new sensors, flexible & printable electronics and wearable energy harvesting devices…
Keystone Nano, Inc., a biopharmaceutical company focused on improving cancer treatments through the application of…
API and MYBiomass announced a Joint-Development Work (JDA) for production of nanocellulose and cellulosic sugars…
A team of researchers at MIT has designed one of the strongest lightweight materials known,…